Subject(s)
Bile Duct Diseases/therapy , Cysts/therapy , Ethanol/administration & dosage , Lymphatic Diseases/therapy , Lymphocele/therapy , Aged , Bile Duct Diseases/complications , Bile Duct Diseases/diagnosis , Female , Humans , Instillation, Drug , Laparoscopy , Liver Diseases/complications , Lymphocele/complications , Lymphocele/diagnosis , Polycystic Kidney Diseases/complicationsABSTRACT
Liver cirrhosis (LC) is often associated with osteomalacia and osteoporosis. Since it has been shown that serum levels of 25 hydroxy vitamin D (25-OH-D) are reduced in LC, defective hepatic hydroxylation of vitamin D has been postulated to be responsible for the low serum 25-OH-D levels and skeletal demineralization. This study was designed, therefore, to determine serum 25-OH-D and 1 alpha, 25-(OH)2-D levels in patients with LC. Further, the response of serum 1 alpha, 25-(OH)2-D to a single oral dose of 1 alpha-OH-D3 (2 micrograms) was investigated. In 5 patients with severe decompensated LC and 3 patients with compensated LC, serum 25-OH-D and 1 alpha, 25-(OH)2-D levels were respectively measured by the modified method of Belsey and by that of Eisman. Serum 25-OH-D in patients with compensated and decompensated LC was significantly higher than that in normals. Serum levels of 1 alpha, 25-(OH)2-D in patients with decompensated LC were significantly lower than those in patients with compensated LC and normals. After a single oral administration of 1 alpha-OH-D3 at a dose of 2 micrograms, the 1 alpha, 25-(OH)2-D rose in each patient within 6h, reaching the maximum levels at 12h. The percent increase over the basal value in decompensated LC was similar to that in compensated LC.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Liver Cirrhosis/metabolism , Vitamin D/metabolism , Dihydroxycholecalciferols/blood , Female , Humans , Hydroxycholecalciferols/blood , Hydroxylation , Kidney/metabolism , Liver Cirrhosis/blood , Liver Cirrhosis/complications , Male , Middle Aged , Osteomalacia/etiology , Osteoporosis/etiologyABSTRACT
Carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and carcinoplacental alkaline phosphatase (CPALP) were detected simultaneously in the sera and body fluids of two male patients with gastric carcinoma matestatic to the liver. At autopsy, widely disseminated gastric cancer of Borrmann III type with liver metastases was revealed in both bases. Histologically, they were moderately differentiated tubular and papillary adenocarcinomas with marked cellular atypia and necrosis. In Case 1, the properties of CPALP were identical to Nagao type CPALP, and in Case 2 the Variant type CPALP. Using immunofluorescence, CEA and CPALP were demonstrated in both primary and metastatic cells. However, only in Case 2 was AFP observed in some of the primary tumor cells.
Subject(s)
Adenocarcinoma, Papillary/metabolism , Antigens, Neoplasm/analysis , Liver Neoplasms/metabolism , Stomach Neoplasms/metabolism , Aged , Alkaline Phosphatase/metabolism , Carcinoembryonic Antigen/metabolism , Fluorescent Antibody Technique , Humans , Liver/pathology , Male , Middle Aged , Neoplasm Metastasis , alpha-Fetoproteins/metabolismSubject(s)
Hepatitis A/immunology , Hepatitis B Antigens/isolation & purification , Acute Disease , Adolescent , Adult , Age Factors , Aged , Antibodies, Viral , Antibody Formation , Antigens, Viral , Child , Chronic Disease , Female , Hepatitis B/immunology , Humans , Male , Middle Aged , Sex Factors , Time Factors , Transfusion ReactionSubject(s)
Hepatitis B Antigens/analysis , Liver/immunology , Acute Disease , Autopsy , Biopsy , Carcinoma, Hepatocellular/immunology , Chronic Disease , Cytoplasm/immunology , Fluorescent Antibody Technique , Hepatitis/immunology , Hepatitis B/immunology , Humans , Liver Cirrhosis/immunology , Liver Diseases/immunology , Liver Neoplasms/immunologySubject(s)
Hepatitis A/immunology , Hepatitis B Antigens , Immune Sera , Acute Disease , Adolescent , Adult , Aged , Child , Female , Hepatitis B Antibodies/analysis , Humans , Male , Middle AgedABSTRACT
The localization of Australia antigen in the liver by the fluorescent antibody technique (direct method) has been studied. Specific fluorescence was observed in the cytoplasm of liver cells. Two distribution patterns of fluorescent-positive cells, namely, a diffuse fluorescence in the liver lobules and a spotty distribution of fluorescent-positive cells, were observed.
